Logo image of ARQQ

ARQIT QUANTUM INC (ARQQ) Stock Fundamental Analysis

NASDAQ:ARQQ - Nasdaq - KYG0567U1278 - Common Stock - Currency: USD

16.9  +0.2 (+1.2%)

After market: 16.94 +0.04 (+0.24%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ARQQ. ARQQ was compared to 281 industry peers in the Software industry. ARQQ may be in some trouble as it scores bad on both profitability and health. ARQQ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ARQQ had negative earnings in the past year.
In the past year ARQQ has reported a negative cash flow from operations.
ARQQ had negative earnings in 4 of the past 5 years.
ARQQ had a negative operating cash flow in each of the past 5 years.
ARQQ Yearly Net Income VS EBIT VS OCF VS FCFARQQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

With a Return On Assets value of -204.28%, ARQQ is not doing good in the industry: 93.95% of the companies in the same industry are doing better.
ARQQ has a Return On Equity of -461.85%. This is amonst the worse of the industry: ARQQ underperforms 82.92% of its industry peers.
Industry RankSector Rank
ROA -204.28%
ROE -461.85%
ROIC N/A
ROA(3y)-74.09%
ROA(5y)-45.92%
ROE(3y)-161.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARQQ Yearly ROA, ROE, ROICARQQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ARQQ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARQQ Yearly Profit, Operating, Gross MarginsARQQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

3

2. Health

2.1 Basic Checks

ARQQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ARQQ has less shares outstanding
ARQQ has a better debt/assets ratio than last year.
ARQQ Yearly Shares OutstandingARQQ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
ARQQ Yearly Total Debt VS Total AssetsARQQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ARQQ has an Altman-Z score of -2.17. This is a bad value and indicates that ARQQ is not financially healthy and even has some risk of bankruptcy.
ARQQ has a worse Altman-Z score (-2.17) than 76.87% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that ARQQ is not too dependend on debt financing.
ARQQ has a Debt to Equity ratio (0.06) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z -2.17
ROIC/WACCN/A
WACC9.24%
ARQQ Yearly LT Debt VS Equity VS FCFARQQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

ARQQ has a Current Ratio of 1.94. This is a normal value and indicates that ARQQ is financially healthy and should not expect problems in meeting its short term obligations.
ARQQ has a Current ratio of 1.94. This is comparable to the rest of the industry: ARQQ outperforms 59.07% of its industry peers.
ARQQ has a Quick Ratio of 1.94. This is a normal value and indicates that ARQQ is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.94, ARQQ perfoms like the industry average, outperforming 59.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.94
ARQQ Yearly Current Assets VS Current LiabilitesARQQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

ARQQ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1933.96%.
Looking at the last year, ARQQ shows a very negative growth in Revenue. The Revenue has decreased by -54.22% in the last year.
EPS 1Y (TTM)-1933.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-258.49%
Revenue 1Y (TTM)-54.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-72.81%

3.2 Future

Based on estimates for the next years, ARQQ will show a very strong growth in Earnings Per Share. The EPS will grow by 28.24% on average per year.
The Revenue is expected to grow by 783.92% on average over the next years. This is a very strong growth
EPS Next Y69.25%
EPS Next 2Y44.18%
EPS Next 3Y28.24%
EPS Next 5YN/A
Revenue Next Year1144.19%
Revenue Next 2Y2230.09%
Revenue Next 3Y783.92%
Revenue Next 5YN/A

3.3 Evolution

ARQQ Yearly Revenue VS EstimatesARQQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 100M 200M 300M
ARQQ Yearly EPS VS EstimatesARQQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ARQQ. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ARQQ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARQQ Price Earnings VS Forward Price EarningsARQQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARQQ Per share dataARQQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as ARQQ's earnings are expected to grow with 28.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.18%
EPS Next 3Y28.24%

More info and screens

0

5. Dividend

5.1 Amount

ARQQ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARQIT QUANTUM INC

NASDAQ:ARQQ (5/2/2025, 8:00:01 PM)

After market: 16.94 +0.04 (+0.24%)

16.9

+0.2 (+1.2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-22 2024-11-22/amc
Earnings (Next)05-19 2025-05-19
Inst Owners7.29%
Inst Owner Change0%
Ins Owners10.66%
Ins Owner ChangeN/A
Market Cap211.25M
Analysts82.86
Price Target53.04 (213.85%)
Short Float %12.53%
Short Ratio1.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)92.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)9.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 720.99
P/FCF N/A
P/OCF N/A
P/B 17.88
P/tB 21.38
EV/EBITDA N/A
EPS(TTM)-10.78
EYN/A
EPS(NY)-1.42
Fwd EYN/A
FCF(TTM)-3
FCFYN/A
OCF(TTM)-2.73
OCFYN/A
SpS0.02
BVpS0.95
TBVpS0.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -204.28%
ROE -461.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-74.09%
ROA(5y)-45.92%
ROE(3y)-161.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1135.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.94
Altman-Z -2.17
F-Score3
WACC9.24%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1331.14%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1933.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-258.49%
EPS Next Y69.25%
EPS Next 2Y44.18%
EPS Next 3Y28.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-54.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-72.81%
Revenue Next Year1144.19%
Revenue Next 2Y2230.09%
Revenue Next 3Y783.92%
Revenue Next 5YN/A
EBIT growth 1Y35.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38.46%
EBIT Next 3Y63.99%
EBIT Next 5YN/A
FCF growth 1Y23.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.95%
OCF growth 3YN/A
OCF growth 5YN/A